These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31173660)

  • 1. A Novel Approach to Chemical Mixture Risk Assessment-Linking Data from Population-Based Epidemiology and Experimental Animal Tests.
    Bornehag CG; Kitraki E; Stamatakis A; Panagiotidou E; Rudén C; Shu H; Lindh C; Ruegg J; Gennings C
    Risk Anal; 2019 Oct; 39(10):2259-2271. PubMed ID: 31173660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to endocrine disrupting chemical mixtures and infant birth weight: A Bayesian analysis using kernel machine regression.
    Hu JMY; Arbuckle TE; Janssen P; Lanphear BP; Zhuang LH; Braun JM; Chen A; McCandless LC
    Environ Res; 2021 Apr; 195():110749. PubMed ID: 33465343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring associations between prenatal exposure to multiple endocrine disruptors and birth weight with exposure continuum mapping.
    Pearce JL; Neelon B; Bloom MS; Buckley JP; Ananth CV; Perera F; Vena J; Hunt K;
    Environ Res; 2021 Sep; 200():111386. PubMed ID: 34087191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical Methodology in Studies of Prenatal Exposure to Mixtures of Endocrine-Disrupting Chemicals: A Review of Existing Approaches and New Alternatives.
    Lazarevic N; Barnett AG; Sly PD; Knibbs LD
    Environ Health Perspect; 2019 Feb; 127(2):26001. PubMed ID: 30720337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
    Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixtures of endocrine-disrupting contaminants induce adverse developmental effects in preweaning rats.
    Axelstad M; Christiansen S; Boberg J; Scholze M; Jacobsen PR; Isling LK; Kortenkamp A; Hass U
    Reproduction; 2014; 147(4):489-501. PubMed ID: 24298046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying windows of susceptibility to endocrine disrupting chemicals in relation to gestational weight gain among pregnant women attending a fertility clinic.
    Tyagi P; James-Todd T; Mínguez-Alarcón L; Ford JB; Keller M; Petrozza J; Calafat AM; Hauser R; Williams PL; Bellavia A;
    Environ Res; 2021 Mar; 194():110638. PubMed ID: 33359703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of individual and combined estrogenic effects of bisphenol, nonylphenol and diethylstilbestrol in immature rats with mathematical models.
    Mao W; Song Y; Sui H; Cao P; Liu Z
    Environ Health Prev Med; 2019 May; 24(1):32. PubMed ID: 31084616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating regulatory guideline values in analysis of epidemiology data.
    Gennings C; Shu H; Rudén C; Öberg M; Lindh C; Kiviranta H; Bornehag CG
    Environ Int; 2018 Nov; 120():535-543. PubMed ID: 30170308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children.
    Midya V; Colicino E; Conti DV; Berhane K; Garcia E; Stratakis N; Andrusaityte S; Basagaña X; Casas M; Fossati S; Gražuleviciene R; Haug LS; Heude B; Maitre L; McEachan R; Papadopoulou E; Roumeliotaki T; Philippat C; Thomsen C; Urquiza J; Vafeiadi M; Varo N; Vos MB; Wright J; McConnell R; Vrijheid M; Chatzi L; Valvi D
    JAMA Netw Open; 2022 Jul; 5(7):e2220176. PubMed ID: 35793087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grouping of endocrine disrupting chemicals for mixture risk assessment - Evidence from a rat study.
    Christiansen S; Axelstad M; Scholze M; Johansson HKL; Hass U; Mandrup K; Frandsen HL; Frederiksen H; Isling LK; Boberg J
    Environ Int; 2020 Sep; 142():105870. PubMed ID: 32593051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism.
    Crofton KM; Craft ES; Hedge JM; Gennings C; Simmons JE; Carchman RA; Carter WH; DeVito MJ
    Environ Health Perspect; 2005 Nov; 113(11):1549-54. PubMed ID: 16263510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mixture of Endocrine Disrupting Chemicals Associated with Lower Birth Weight in Children Induces Adipogenesis and DNA Methylation Changes in Human Mesenchymal Stem Cells.
    Lizunkova P; Engdahl E; Borbély G; Gennings C; Lindh C; Bornehag CG; Rüegg J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empirical approach to sufficient similarity: combining exposure data and mixtures toxicology data.
    Marshall S; Gennings C; Teuschler LK; Stork LG; Tornero-Velez R; Crofton KM; Rice GE
    Risk Anal; 2013 Sep; 33(9):1582-95. PubMed ID: 23398277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections.
    García-Peñarrubia P; Ruiz-Alcaraz AJ; Martínez-Esparza M; Marín P; Machado-Linde F
    Hum Reprod Update; 2020 Feb; 26(2):214-246. PubMed ID: 32108227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term transcriptional and behavioral effects in mice developmentally exposed to a mixture of endocrine disruptors associated with delayed human neurodevelopment.
    Repouskou A; Papadopoulou AK; Panagiotidou E; Trichas P; Lindh C; Bergman Å; Gennings C; Bornehag CG; Rüegg J; Kitraki E; Stamatakis A
    Sci Rep; 2020 Jun; 10(1):9367. PubMed ID: 32518293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposures to mixtures of endocrine disrupting chemicals and sex-specific associations with children's BMI and overweight at 5.5 years of age in the SELMA study.
    Svensson K; Gennings C; Lindh C; Kiviranta H; Rantakokko P; Wikström S; Bornehag CG
    Environ Int; 2023 Sep; 179():108176. PubMed ID: 37672941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-pollutant assessment of preconception persistent endocrine disrupting chemicals and incident pregnancy loss.
    Smarr MM; Mirzaei Salehabadi S; Boyd Barr D; Buck Louis GM; Sundaram R
    Environ Int; 2021 Dec; 157():106788. PubMed ID: 34332300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to persistent and nonpersistent endocrine-disrupting chemicals and anogenital distance. A systematic review of epidemiological studies†.
    Nelson W; Liu DY; Yang Y; Zhong ZH; Wang YX; Ding YB
    Biol Reprod; 2020 Feb; 102(2):276-291. PubMed ID: 31621835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.